republic-os/legislation/us/states/co/2025a/sb-25-164.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Opioid Antagonist Availability & State Board of Health	The act requires the state board of health (board) to allow the Colorado youth advisory council (council) to present to the board twice a year on issues regarding the youth opioid epidemic and other health issues. The act also allows the council to consult the prevention services division within the department of public health and environment during the stakeholding process for rule-making regarding opioid antagonists.	us/states/co	Colorado General Assembly	2025A	SB 25-164	Colorado SB 25-164 (2025A)	bill		enacted	Faith Winter Jamie Jackson Janice Marchman Jenny Willford	9	13	2	2025-02-14T07:00:00+00:00	2025-05-05T06:00:00+00:00	openstates	ocd-bill/22b87cac-8c02-4b8a-beab-aa8d29e45d13	https://leg.colorado.gov/bills/sb25-164	0e596cc8175f131dcc2a690d6089bef4b085a158f8f313a2373acf02363363b9	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-co

Colorado SB 25-164 (2025A) — Opioid Antagonist Availability & State Board of Health

The act requires the state board of health (board) to allow the Colorado youth advisory council (council) to present to the board twice a year on issues regarding the youth opioid epidemic and other health issues. The act also allows the council to consult the prevention services division within the department of public health and environment during the stakeholding process for rule-making regarding opioid antagonists.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Committee Amendment (committee substitute) — source
2. Engrossed (03/18/2025) (committee substitute) — source
3. Final Act (04/25/2025) (committee substitute) — source
4. Introduced (02/14/2025) (committee substitute) — source
5. PA1 (03/14/2025) (committee substitute) — source
6. Reengrossed (03/19/2025) (committee substitute) — source
7. Rerevised (04/15/2025) (committee substitute) — source
8. Revised (04/14/2025) (committee substitute) — source
9. Signed Act (05/05/2025) (committee substitute) — source

Votes

• BILL — 32–2 (pass) · upper
• BILL — 61–1 (pass) · lower

Sponsors

• Faith Winter — primary (person)
• Jamie Jackson — primary (person)
• Janice Marchman — primary (person)
• Jenny Willford — primary (person)
• A. Boesenecker — cosponsor (person)
• A. Valdez — cosponsor (person)
• B. Bradley — cosponsor (person)
• C. Clifford — cosponsor (person)
• C. Kipp — cosponsor (person)
• C. Kolker — cosponsor (person)
• D. Michaelson Jenet — cosponsor (person)
• E. Sirota — cosponsor (person)
• I. Jodeh — cosponsor (person)
• J. Amabile — cosponsor (person)
• J. Bacon — cosponsor (person)
• J. Caldwell — cosponsor (person)
• J. Coleman — cosponsor (person)
• J. Joseph — cosponsor (person)
• J. Mabrey — cosponsor (person)
• J. McCluskie — cosponsor (person)
• J. Phillips — cosponsor (person)
• K. Brown — cosponsor (person)
• K. McCormick — cosponsor (person)
• K. Stewart — cosponsor (person)
• L. Cutter — cosponsor (person)
• L. Smith — cosponsor (person)
• M. Duran — cosponsor (person)
• M. Froelich — cosponsor (person)
• M. Lindsay — cosponsor (person)
• M. Snyder — cosponsor (person)
• M. Weissman — cosponsor (person)
• N. Hinrichsen — cosponsor (person)
• S. Bird — cosponsor (person)
• S. Lieder — cosponsor (person)
• S. Woodrow — cosponsor (person)
• T. Sullivan — cosponsor (person)
• T. Winter — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2025-05-05T06:00:00+00:00 Governor Signed executive-signature
• 2025-04-25T06:00:00+00:00 Sent to the Governor executive-receipt
• 2025-04-25T06:00:00+00:00 Signed by the Speaker of the House
• 2025-04-24T06:00:00+00:00 Signed by the President of the Senate
• 2025-04-15T06:00:00+00:00 House Third Reading Passed - No Amendments passage, reading-3
• 2025-04-14T06:00:00+00:00 House Second Reading Special Order - Passed - No Amendments
• 2025-04-11T06:00:00+00:00 House Second Reading Laid Over Daily - No Amendments
• 2025-04-08T06:00:00+00:00 House Committee on Health & Human Services Refer Unamended to House Committee of the Whole committee-passage, referral-committee
• 2025-03-19T06:00:00+00:00 Introduced In House - Assigned to Health & Human Services introduction
• 2025-03-19T06:00:00+00:00 Senate Third Reading Passed - No Amendments passage, reading-3
• 2025-03-18T06:00:00+00:00 Senate Second Reading Passed with Amendments - Committee reading-2
• 2025-03-13T06:00:00+00:00 Senate Committee on Health & Human Services Refer Amended to Senate Committee of the Whole committee-passage, referral-committee
• 2025-02-14T07:00:00+00:00 Introduced In Senate - Assigned to Health & Human Services introduction

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/22b87cac-8c02-4b8a-beab-aa8d29e45d13. Confidence: reported (aggregated from official Colorado legislature records).